Edition:
India

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.50USD
10:52pm IST
Change (% chg)

$-0.02 (-1.32%)
Prev Close
$1.52
Open
$1.52
Day's High
$1.52
Day's Low
$1.50
Volume
3,469
Avg. Vol
14,812
52-wk High
$3.41
52-wk Low
$1.29

Latest Key Developments (Source: Significant Developments)

Cyclacel Pharma Projects Cash Resources To Fund Currently Planned Programs Through End Of 2019
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Cyclacel Pharmaceuticals Inc ::CYCLACEL PHARMACEUTICALS INC - CO PROJECTS CASH RESOURCES TO FUND CURRENTLY PLANNED PROGRAMS THROUGH END OF 2019.  Full Article

Cyclacel Pharmaceuticals Q3 loss per share $0.91 including items
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Cyclacel Pharmaceuticals Inc ::Cyclacel Pharmaceuticals reports third quarter 2017 financial results.Q3 loss per share $0.91 including items.  Full Article

Tang Capital Partners Lp says 9.6 pct stake in Cyclacel Pharmaceuticals
Saturday, 20 Aug 2016 

Tang Capital Partners Lp:Tang Capital Partners Lp reports 9.6 pct passive stake in Cyclacel Pharmaceuticals Inc as of Aug 12 - SEC Filing.  Full Article

Cyclacel Pharma Q2 shr loss $1.01
Thursday, 11 Aug 2016 

Cyclacel Pharmaceuticals Inc : Cyclacel pharmaceuticals reports 2nd quarter 2016 financial results . Cyclacel pharmaceuticals q2 shr loss $1.01 . Cyclacel pharmaceuticals q2 revenue $200,000 vs $300,000 .Cyclacel says estimates that it has capital resources to reach beyond final analysis of seamless and continue existing programs through q1 of 2018.  Full Article

BRIEF-Cyclacel Pharmaceuticals Posts Qtrly Loss Of $2.1 Mln

* CYCLACEL PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS